Abstract: Extranodal natural killer (NK)/T-cell lymphoma, nasal type, is a rare type of cytotoxic lymphoma involving mainly the upper aerodigestive tract and associated with Epstein-Barr virus. The disease has usually a poor prognosis related to several factors. The skin is the second most common affected organ, and cases may be localized to the skin only without any other extracutaneous manifestations. Although primary cutaneous cases may have a better prognosis, survival usually is still poor. We report a case of primary cutaneous extranodal NK/T-cell lymphoma, nasal type, in a 77-year-old woman with an indolent course for more than 22 years and still limited to the skin.
INTRODUCTION
Extranodal natural killer (NK)/T-cell lymphoma, nasal type, is a rare type of cytotoxic lymphoma associated with Epstein-Barr virus (EBV) and involving mainly the upper aerodigestive tract. 1 The disease has a poor prognosis related to factors such as extranasal location, stage, performance status, and the number of extranodal involvement, as well as to the type of treatment. [2] [3] [4] [5] The skin is the second most common affected organ, and cases may be localized to the skin only without any other extracutaneous manifestations. 6 We report a case of primary cutaneous extranodal NK/T-cell lymphoma, nasal type, with a remarkably indolent course over a period of 22 years.
CASE REPORT
A white woman first presented to the Department of Dermatology of the University of Graz in January 1989 at the age of 55 years with a large, red-violaceous, infiltrated plaque on the right upper arm. A biopsy was diagnosed at that time as a reactive lymphoid infiltrate (''nonfollicular pseudolymphoma''). Sonography of the lymph nodes and of the abdomen and routine blood investigations were normal. A final diagnosis of pseudolymphoma was made, and the patient underwent local radiotherapy with complete resolution of the lesion. She was disease free for the next 16 years. In 2005, she presented at another institution with a recurrent plaque in the same location. Histologic examination disclosed a cytotoxic infiltrate with features of NK/Textranodal cytotoxic lymphoma, nasal type (slides not available for review). Complete staging investigations (including total body computed tomography, lymph node sonography, and bone marrow biopsy) were negative. Examination of the upper respiratory tract was negative. The patient underwent 6 cycles of chemotherapy Cyclophosphamide, Adriamycin, Vincristine, Prednisone (CHOP) with complete remission. After a 6-year disease-free period, she presented again at our institution in February 2011 with a recurrent plaque located again at the same site on the right upper arm (Fig. 1) . A new biopsy specimen revealed features of extranodal NK/T-cell lymphoma, nasal type, with positive in situ hybridization for EBV (EBER-1). Repeated complete staging investigations were again negative for extracutaneous disease. Lactate dehydrogenase and b-globulin were within normal limits. The patient did not have nasal symptoms such as epistaxis or chronic sinusitis; repeated examination of the upper respiratory tract was negative. The case was discussed in a tumour board at our institution, and the decision to treat the recurrent lesion with local radiotherapy was taken.
The biopsy of 1989 was reevaluated. Microscopically, both biopsies (1989 and 2011) exhibited the same pattern with a diffuse proliferation of atypical lymphoid cells throughout the dermis, admixed with small lymphocytes (Figs. 2A, B) . The malignant cells were predominantly mid-sized pleomorphic lymphocytes (Fig. 2C) showing infiltration and destruction of adnexal structures (Fig. 2D) . Neither angiocentricity/angiodestruction nor necrosis or epidermotropism was noted. Hemophagocytosis was not present.
Immunohistochemical studies performed on both specimens revealed that neoplastic cells were CD2 + , cytoplasmic CD3 + , TIA-1 + , and granzyme B + but negative for CD4, CD5, CD8, CD20, CD30, and b-F1 (Figs. 3A-C). Staining for CD56 was negative in the specimen of 1989 but weakly positive in that of 2011. The proliferation rate of neoplastic cells (Ki-67) was .90% in both biopsies (Fig. 3D) . In situ hybridization for EBER-1 was strongly positive in both specimens (Fig. 4) . Polymerase chain reaction analyses of the T-cell receptor genes were performed according to the BIOMED-2 protocol in the 2011 biopsy, revealing a polyclonal pattern.
DISCUSSION
We present an exceptional case of primary cutaneous extranodal NK/T-cell lymphoma, nasal type, with indolent behavior and only cutaneous recurrences over a period of 22 years. Extranodal NK/T-cell lymphoma, nasal type, is a disease with an aggressive course and usually poor prognosis. [1] [2] [3] [4] [5] The skin is the second commonest site of involvement after the upper respiratory tract. Other sites of involvement are the gastrointestinal system, soft tissue, brain, liver, spleen, bone marrow, and testis. 2 Prognosis has been recently related to factors such as extranasal location, stage, performance status, and the number of extranodal involvement, as well as to the type of treatment. [3] [4] [5] Other prognostic factors have been related to high circulating EBV-DNA levels and the presence of EBV+ cells in the bone marrow. 1, 7 The value of cytomorphologic features is still debated, but it seems that cytomorphology does not play any prognostic role. One study suggested that local tumor invasiveness is more predictive of patient survival than the International Prognostic Index (IPI). 8 Quintanilla-Martinez et al 9 reported an association between p53 mutations with large cell morphology and advanced disease. Although prognosis of primary cutaneous cases may be slightly better, 1 the disease usually runs an aggressive course, and prolonged survival is rare. A recent study by Choi et al 10 showed that patients with disease limited to the skin only had a better survival rate. Similar findings were reported also by Bekkenk et al. 11 However, in both studies, survival was still short, despite disease confined to the skin at presentation. A case with a 10-year indolent course finally developing an aggressive clinical behavior was reported by Watabe et al 6 in 2008 in Japan. Hematophagocytosis and bone marrow involvement were associated with progressive disease and death in this patient. 6 A review of 42 cases of extranodal NK/T-cell lymphoma, nasal type, in Singapore showed a mean survival time of 30 months with only 3 patients (7%) surviving for more than 5 years. 2 The longest survival was observed in 1 patient who died after 8 years and 11 months. Our patient was disease free for 16 years, despite a local treatment with radiotherapy and again in complete remission for 6 years after 6 cycles of CHOP following local skin relapse. All recurrences occurred at the same anatomic site on the right upper arm, and no signs of extracutaneous disease were detected with complete staging investigations in 2005 and 
(investigations in 1989
were limited as a diagnosis of pseudolymphoma was provided at that time but were negative as well), thus suggesting that in this patient, the disease persisted subclinically for many years before giving rise to local relapses. The course in our patient is remarkably indolent, especially considering that recurrences are almost invariably accompanied by rapidly progressive disease 12 and that no case of recurrence at the same site has been reported in the literature. In addition, it is remarkable that morphologic and phenotypic features of the first biopsy, as judged on reevaluation, showed aggressive aspects with infiltration and destruction of adnexal structures and a proliferation rate of .90% of neoplastic cells.
Besides the favorable outcome, our case shows other peculiar features such as CD56 negativity (only the 2011 specimen was weakly positive) and the lack of angiodestruction. However, neither of these features is a prerequisite for the diagnosis of extranodal NK/T-cell lymphoma, nasal-type, and other aspects were consistent with this diagnosis (strong positivity for EBV, cytotoxic phenotype, high proliferation, infiltration, and destruction of adnexal structures). The differential diagnosis includes other cutaneous aggressive cytotoxic lymphomas. Tumor stage mycosis fungoides could be ruled out by the lack of history of previous mycosis fungoides and the absence of other skin lesions. Aggressive epidermotropic CD8
+ cytotoxic T-cell lymphoma was excluded because of the lack of positivity for CD8 and the lack of epidermotropism. Cutaneous gamma/delta T-cell lymphoma is the most important differential diagnosis. However, the lack of expression of CD5 and the lack of monoclonal TCR-gene rearrangement would be unusual. In addition, strong EBER-1 positivity would be highly unusual in all these cytotoxic lymphomas.
In conclusion, we presented an exceptional case of extranodal NK/T-cell lymphoma, nasal type, with indolent course and the longest survival ever observed in this aggressive cytotoxic lymphoma.
